BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19917688)

  • 41. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
    David L; Li Y; Ma J; Garner E; Zhang X; Wu H
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
    McCully RR; Pomerantz JL
    Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usp9X Is Required for Lymphocyte Activation and Homeostasis through Its Control of ZAP70 Ubiquitination and PKCβ Kinase Activity.
    Naik E; Dixit VM
    J Immunol; 2016 Apr; 196(8):3438-51. PubMed ID: 26936881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of CARMA1: the link(er) to NF-kappaB activation.
    Rueda D; Thome M
    Immunity; 2005 Dec; 23(6):551-3. PubMed ID: 16356853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.
    Lin Q; Liu Y; Moore DJ; Elizer SK; Veach RA; Hawiger J; Ruley HE
    J Immunol; 2012 Mar; 188(6):2493-7. PubMed ID: 22323537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.
    Gaide O; Favier B; Legler DF; Bonnet D; Brissoni B; Valitutti S; Bron C; Tschopp J; Thome M
    Nat Immunol; 2002 Sep; 3(9):836-43. PubMed ID: 12154360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The molecular adapter Carma1 controls entry of IkappaB kinase into the central immune synapse.
    Hara H; Bakal C; Wada T; Bouchard D; Rottapel R; Saito T; Penninger JM
    J Exp Med; 2004 Nov; 200(9):1167-77. PubMed ID: 15520247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation.
    Egawa T; Albrecht B; Favier B; Sunshine MJ; Mirchandani K; O'Brien W; Thome M; Littman DR
    Curr Biol; 2003 Jul; 13(14):1252-8. PubMed ID: 12867038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Knock-down of CARMA1 in K562 cells inhibits the invasion and metastasis of K562 cells].
    Liu F; Wang L; Li J; Chen S; Ye Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):691-5. PubMed ID: 25001930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator.
    Stilo R; Liguoro D; Di Jeso B; Formisano S; Consiglio E; Leonardi A; Vito P
    J Biol Chem; 2004 Aug; 279(33):34323-31. PubMed ID: 15184390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PKCθ synergizes with TLR-dependent TRAF6 signaling pathway to upregulate MUC5AC mucin via CARMA1.
    Jono H; Lim JH; Xu H; Li JD
    PLoS One; 2012; 7(1):e31049. PubMed ID: 22303480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dlgh1 and Carma1 MAGUK proteins contribute to signal specificity downstream of TCR activation.
    Rebeaud F; Hailfinger S; Thome M
    Trends Immunol; 2007 May; 28(5):196-200. PubMed ID: 17395537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NF-kappaB signaling in lymphocytes: a new cast of characters.
    Lucas PC; McAllister-Lucas LM; Nunez G
    J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
    Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
    J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-κB signalling.
    Hara H; Yokosuka T; Hirakawa H; Ishihara C; Yasukawa S; Yamazaki M; Koseki H; Yoshida H; Saito T
    Nat Commun; 2015 Jan; 6():5555. PubMed ID: 25602919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.
    Bunnell SC
    Mol Interv; 2002 Oct; 2(6):356-60, 338. PubMed ID: 14993411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The MAGUK family protein CARD11 is essential for lymphocyte activation.
    Hara H; Wada T; Bakal C; Kozieradzki I; Suzuki S; Suzuki N; Nghiem M; Griffiths EK; Krawczyk C; Bauer B; D'Acquisto F; Ghosh S; Yeh WC; Baier G; Rottapel R; Penninger JM
    Immunity; 2003 Jun; 18(6):763-75. PubMed ID: 12818158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
    Bidère N; Snow AL; Sakai K; Zheng L; Lenardo MJ
    Curr Biol; 2006 Aug; 16(16):1666-71. PubMed ID: 16920630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells.
    Park SG; Schulze-Luehrman J; Hayden MS; Hashimoto N; Ogawa W; Kasuga M; Ghosh S
    Nat Immunol; 2009 Feb; 10(2):158-66. PubMed ID: 19122654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation.
    Thome M
    Nat Rev Immunol; 2004 May; 4(5):348-59. PubMed ID: 15122200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.